Cargando…
Recombinant adenovirus-p53 enhances the therapeutic effect of surgery and chemoradiotherapy combination in hypopharyngeal squamous cell carcinomas patients
The purpose of our study was to assess the safety and efficacy of recombinant adenovirus-p53 (rAd-p53) combined with surgery and chemoradiotherapy (CRT) for patients with hypopharyngeal squamous cell carcinomas (HPSCC). This study retrospectively and consecutively collected clinical data of 102 pati...
Autores principales: | Liu, Jun, Lv, Dan, Wang, Haiyang, Zou, Jian, Chen, Fei, Yang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393013/ https://www.ncbi.nlm.nih.gov/pubmed/30170471 http://dx.doi.org/10.1097/MD.0000000000012193 |
Ejemplares similares
-
The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
por: Omura, Go, et al.
Publicado: (2017) -
The Prognostic Prediction Value of Positive Lymph Nodes Numbers for the Hypopharyngeal Squamous Cell Carcinoma
por: Pang, Wendu, et al.
Publicado: (2022) -
Boerhaave syndrome due to hypopharyngeal stenosis associated with chemoradiotherapy for hypopharyngeal cancer: a case report
por: Tanaka, Hideharu, et al.
Publicado: (2018) -
Treatment outcomes of definitive chemoradiotherapy for patients with hypopharyngeal cancer
por: Nakahara, Rie, et al.
Publicado: (2012) -
Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy
por: Ng, Shu-Hang, et al.
Publicado: (2013)